✦ LIBER ✦

PEY16 COST-UTILITY ANALYSIS FOR PEGAPTANIB IN AGE-RELATED MACULAR DEGENERATION IN THE UK: THE IMPACT OF DEMOGRAPHIC AND DISEASE CHARACTERISTICS

✍ Scribed by S Wolowacz; N Roskell; F Maciver; S Kelly

Book ID: 119594618
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 71 KB
Volume: 9
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)63722-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PEY17 COST-EFFECTIVENESS OF PEGAPTANIB I

PEY17 COST-EFFECTIVENESS OF PEGAPTANIB IN AGE-RELATED MACULAR DEGENERATION: IMPACT OF DIFFERENCES BETWEEN US AND UK HEALTH CARE SYSTEMS

✍ J Javitt; S Wolowacz; N Roskell; S Maciver; S Kelly; A Pleil; G Zlateva 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PSS13 COST-EFFECTIVE ANALYSIS OF PEGAPTA

PSS13 COST-EFFECTIVE ANALYSIS OF PEGAPTANIB (MACUGEN®) AS COMPARED WITH RANIBIZUMAB (LUCENTIS®) FOR TREATING IN AGE-RELATED MACULAR DEGENERATION (AMD)

✍ LY Lu; W McGhan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PSS19 A PHARMACOECONOMIC EVALUATION OF P

PSS19 A PHARMACOECONOMIC EVALUATION OF PEGAPTANIB FOR THE MANAGEMENT OF AGE-RELATED MACULAR DEGENERATION (AMD) IN MEXICO

✍ GY Vega-Hernández; J Idrovo-Velandia; R Rivas; L Zapata; J Venegas; H Ramírez; J 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Cost-Effectiveness Analysis of Ranibizum

Cost-Effectiveness Analysis of Ranibizumab versus Verteporfin Photodynamic Therapy, Pegaptanib Sodium, and Best Supportive Care for the Treatment of Age-Related Macular Degeneration in Greece

✍ Kostas Athanasakis; Vasilios Fragoulakis; Vasiliki Tsiantou; Panagiotis Masaouti 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 551 KB

Author Response: Additional Consideratio

Author Response: Additional Considerations in the Utility of Dark Adaptometry for the Diagnosis of Age-Related Macular Degeneration

✍ Jackson, Gregory R.; Scott, Ingrid U.; Kim, Ivana K.; Quillen, David A.; Iannacc 📂 Article 📅 2014 🏛 Association for Research in Vision and Ophthalmolo ⚖ 63 KB

Incidence and baseline clinical characte

Incidence and baseline clinical characteristics of treated neovascular age-related macular degeneration in a well-defined region of the UK

✍ Keenan, T. D. L.; Kelly, S. P.; Sallam, A.; Mohamed, Q.; Tufail, A.; Johnston, R 📂 Article 📅 2013 🏛 BMJ Publishing Group 🌐 English ⚖ 313 KB